Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

June 10, 2018

Skin Tone, Race May Be Associated With Multiple Sclerosis Diagnosis

  • MS Research Study and Reports
    /
A study has shown that children with acquired demyelinating syndromes (ADSs) who report a lighter skin tone and a non-white…
MS Research Study and Reports

June 10, 2018

Multiple Sclerosis Pain Common Disruptive Factor in Everyday Activities

  • MS Pain and Side Effects
    /
The following article is part of conference coverage from the 2018 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Nashville,…
MS Pain and Side Effects

June 10, 2018

Some Multiple Sclerosis Agents May be Safe During Pregnancy

  • MS Research Study and Reports
    /
by Salynn Boyles, Contributing Writer June 05, 2018 NASHVILLE — Questions are now being raised about recent recommendations that clinicians…
MS Research Study and Reports

May 28, 2018

OhioHealth Multiple Sclerosis Lecture – How to Know Your Therapy is Working

  • MS Drug Therapies
    /
  • MS Educational Programs
    /
  • Multiple Sclerosis Videos
    /
Dr. Jacqueline Nicholas, OhioHealth MS neurologist, speaks how disease modifying MS therapies can help prevent new attacks over time and…
MS Drug Therapies

May 23, 2018

MS and Mental Illness

  • Misc. MS Related
    /
MAY 22, 2018    BY TERESA WRIGHT-JOHNSON Spring has sprung! As I look around, Mother Earth is in bloom. Trees are sprouting…
Misc. MS Related

May 23, 2018

Subcutaneous Ofatumumab a Safe, Effective RRMS Therapy at Low Doses, Trial Results Show

  • MS Research Study and Reports
    /
May 23rd, 2018 A formulation of ofatumumab (brand name Arzerra) to be injected under the skin (subcutaneous) was found to be safe and effective…
MS Research Study and Reports

May 23, 2018

Sativex Can Improve Driving Ability of MS Patients, Study Says

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
May 22, 2018 Sativex, a cannabis-based anti-spasticity medicine commercialized as oromucosal spray by GW Pharmaceuticals, improves the driving ability of patients with multiple…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

May 15, 2018

#CMSC2018 – Julie Roberts, Country Music Singer and MS Advocate, Performing at CMSC Meeting

  • MS Educational Programs
    /
Julie Roberts, a country music singer and multiple sclerosis (MS) patient advocate, will perform at the upcoming Consortium of Multiple Sclerosis Centers (CMSC)’s annual…
MS Educational Programs

May 15, 2018

Doctor Discussion Guide: Newly Diagnosed with MS

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Learning you have multiple sclerosis can be alarming and frightening. Here are some questions to ask your doctor about your…
Additional MS resource sites

May 12, 2018

Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Pediatric MS
    /
 New approval for Gilenya (fingolimod) addresses strong unmet need for younger patients, who often experience more frequent relapses than adults…
MS Drug Therapies

Categories

Latest Blog Posts